GLP-1s are changing US healthcare, should everyone be on them?
GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US. As research uncovers potential benefits beyond weight loss, experts are asking whether these medications could one day be used far more widely.
Originally reported by Al Jazeera. Read the full story at the original source.
Government flags criminal law changes to ensure companies can’t argue in future ‘that someone didn’t know the computer w...
Runners seek medical treatment as 13-mile race held amid unusually high November temperaturesPolice in southern Californ...
xwhatsapp-strokecopylinkgoogleAdd Al Jazeera on GoogleinfoCameroon's President Paul Biya speaks with players and officia...
Israel’s Shin Bet finds no evidence of foreign election interference Israel’s Shin Bet, the country’s internal security ...